Colin Kerr
Published: Monday, April 1, 2019

NIDEK has launched AngioScan, an upgraded OCT-Angiography software, that enables visualisation of retinal and choroidal microvasculature and blood flow using the RS-3000 Advance 2 Optical Coherence Tomography.
“The new analysis function quantifies vessels in each layer providing metrics to assess disease progression and the effects of treatment. The NIDEK AngioScan [also] presents a vessel density map and a perfusion density map. Additionally, the foveal avascular zone (FAZ) is automatically detected and shape metrics are provided for rapid assessment,” said a company spokesman.
“A newly designed interface displays seven slabs for each layer on one screen. The interface is intuitive and summary charts facilitate quick evaluation of the most relevant clinical features.”
Improved image-processing algorithms enable visualisation of sub-clinical neovascularisation. New projection artifact removal algorithms provide an accurate representation of vasculature by reducing artifacts for better OCT-angiography image interpretation,
say Nidek.
www.nidek-intl.com
Tags: oct
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
Read more...
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Read more...
ESCRS Today 2025: All Eyes on Innovation
Watching out for obstacles and opportunities
Read more...
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Read more...
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Read more...
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Read more...
Supplement: ESCRS Clinical Trends Series: Presbyopia
Read more...
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Read more...
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Read more...
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Read more...